Join to View Full Profile
747 52nd StOakland, CA 94609
Phone+1 510-428-3058
Fax+1 510-450-5813
Dr. Harmatz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Gastroenterology, 1979 - 1982
Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 1976 - 1979
Geisel School of Medicine at DartmouthClass of 1976
Certifications & Licensure
CA State Medical License 1977 - 2027
FL State Medical License 2021 - 2027
MI State Medical License 2024 - 2027
MT State Medical License 2022 - 2026
NM State Medical License 2023 - 2026
OH State Medical License 2022 - 2026
WA State Medical License 2023 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Gastroenterology
- Join now to see all
Clinical Trials
- Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment Start of enrollment: 2006 Feb 01
- Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Start of enrollment: 2007 Jul 25
- A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsOral Infigratinib Therapy in Children with Achondroplasia.Ravi Savarirayan, Josep Maria De Bergua, Paul Arundel, Jean Pierre Salles, Vrinda Saraff
The New England Journal of Medicine. 2025-02-27 - Prenatal Delivery of Enzyme Replacement Therapy to Fetuses Affected by Early-Onset Lysosomal Storage Diseases.Beltran Borges, Emma Canepa, Irene J Chang, Akos Herzeg, Billie Lianoglou
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 2025-01-31 - Sustained growth-promoting effects of vosoritide in children with achondroplasia from an ongoing phase 3 extension study.Ravi Savarirayan, Melita Irving, William R Wilcox, Carlos A Bacino, Julie E Hoover-Fong
Med. 2024-12-30
Press Mentions
REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025January 30th, 2025- Rare, Deadly Genetic Disease Successfully Treated in Utero for First TimeNovember 9th, 2022
BioMarin Announces New and Updated Data at 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting Demonstrating Commitment to Understanding Achondroplasia and Potential Treatment ChoiceApril 15th, 2021- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
